Michelle R. vanDellen , Emma Bales , Brittnee M. Hampton , Eshita Jain , Ye Shen , Jayani Jayawardhana , Steven R.H. Beach , Ashley H. Chinchilla , James M. MacKillop
{"title":"评估双吸烟夫妇中涉及伴侣的经济激励戒烟治疗:一项随机对照试验方案。","authors":"Michelle R. vanDellen , Emma Bales , Brittnee M. Hampton , Eshita Jain , Ye Shen , Jayani Jayawardhana , Steven R.H. Beach , Ashley H. Chinchilla , James M. MacKillop","doi":"10.1016/j.cct.2025.108076","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Individuals who smoke combustible nicotine cigarettes and are partnered with another smoker are less likely to quit smoking than other smokers. Financial incentives for cessation increase individual abstinence. However, these interventions have not been examined using a dyadic approach that targets the couple rather than an individual. The current study will evaluate two variants of a dyadic financial incentive intervention for smoking cessation in dual-smoking couples.</div></div><div><h3>Methods</h3><div>Feasibility and tolerability of dyadic financial incentive treatments in dual-smoking couples has been established, along with their preliminary efficacy. The current study will utilize a large-scale clinical trial to systematically evaluate the efficacy and mechanisms of change of two variants of dyadic financial incentive interventions among 450 dual-smoking couples.</div></div><div><h3>Results</h3><div>The primary study outcome will be 6-month point-prevalence abstinence (self-report abstinence for 7 days + biochemical verification) among targets in dual-smoking couples. Partner abstinence at 6-months, and both target and partner abstinence at 1, 3, and 12 months will be examined as secondary outcomes. Potential treatment mechanisms, including motivational and relationship processes will be evaluated to inform future interventions.</div></div><div><h3>Discussion</h3><div>Individuals with smoking partners experience low motivation to quit and low success rates when they make quit attempts. Current evidence-based interventions target individuals in isolation from their social networks that strongly influence them. This approach represents a critical next step toward developing interventions that effectively capitalize on social network members to produce and sustain smoking cessation.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"158 ","pages":"Article 108076"},"PeriodicalIF":1.9000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluating partner-involved financial incentive treatments for smoking cessation in dual-smoker couples: A randomized controlled trial protocol\",\"authors\":\"Michelle R. vanDellen , Emma Bales , Brittnee M. Hampton , Eshita Jain , Ye Shen , Jayani Jayawardhana , Steven R.H. Beach , Ashley H. Chinchilla , James M. MacKillop\",\"doi\":\"10.1016/j.cct.2025.108076\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Individuals who smoke combustible nicotine cigarettes and are partnered with another smoker are less likely to quit smoking than other smokers. Financial incentives for cessation increase individual abstinence. However, these interventions have not been examined using a dyadic approach that targets the couple rather than an individual. The current study will evaluate two variants of a dyadic financial incentive intervention for smoking cessation in dual-smoking couples.</div></div><div><h3>Methods</h3><div>Feasibility and tolerability of dyadic financial incentive treatments in dual-smoking couples has been established, along with their preliminary efficacy. The current study will utilize a large-scale clinical trial to systematically evaluate the efficacy and mechanisms of change of two variants of dyadic financial incentive interventions among 450 dual-smoking couples.</div></div><div><h3>Results</h3><div>The primary study outcome will be 6-month point-prevalence abstinence (self-report abstinence for 7 days + biochemical verification) among targets in dual-smoking couples. Partner abstinence at 6-months, and both target and partner abstinence at 1, 3, and 12 months will be examined as secondary outcomes. Potential treatment mechanisms, including motivational and relationship processes will be evaluated to inform future interventions.</div></div><div><h3>Discussion</h3><div>Individuals with smoking partners experience low motivation to quit and low success rates when they make quit attempts. Current evidence-based interventions target individuals in isolation from their social networks that strongly influence them. This approach represents a critical next step toward developing interventions that effectively capitalize on social network members to produce and sustain smoking cessation.</div></div>\",\"PeriodicalId\":10636,\"journal\":{\"name\":\"Contemporary clinical trials\",\"volume\":\"158 \",\"pages\":\"Article 108076\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contemporary clinical trials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1551714425002708\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425002708","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Evaluating partner-involved financial incentive treatments for smoking cessation in dual-smoker couples: A randomized controlled trial protocol
Background
Individuals who smoke combustible nicotine cigarettes and are partnered with another smoker are less likely to quit smoking than other smokers. Financial incentives for cessation increase individual abstinence. However, these interventions have not been examined using a dyadic approach that targets the couple rather than an individual. The current study will evaluate two variants of a dyadic financial incentive intervention for smoking cessation in dual-smoking couples.
Methods
Feasibility and tolerability of dyadic financial incentive treatments in dual-smoking couples has been established, along with their preliminary efficacy. The current study will utilize a large-scale clinical trial to systematically evaluate the efficacy and mechanisms of change of two variants of dyadic financial incentive interventions among 450 dual-smoking couples.
Results
The primary study outcome will be 6-month point-prevalence abstinence (self-report abstinence for 7 days + biochemical verification) among targets in dual-smoking couples. Partner abstinence at 6-months, and both target and partner abstinence at 1, 3, and 12 months will be examined as secondary outcomes. Potential treatment mechanisms, including motivational and relationship processes will be evaluated to inform future interventions.
Discussion
Individuals with smoking partners experience low motivation to quit and low success rates when they make quit attempts. Current evidence-based interventions target individuals in isolation from their social networks that strongly influence them. This approach represents a critical next step toward developing interventions that effectively capitalize on social network members to produce and sustain smoking cessation.
期刊介绍:
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.